Buscar por Tema ENFERMEDAD DE PARKINSON


O bien, seleccione una letra de abajo para navegar por tema
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrando resultados 5 a 24 de 38 < Anterior   Siguiente >
Vista previaFecha de publicaciónTítuloAutor(es)
deficits-cholinergic-neurotransmission.pdf.jpg2016Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s diseasePérez Lloret, Santiago ; Barrantes, Francisco José 
diagnosis-management-pain.pdf.jpg2021Diagnosis and management of pain in Parkinson’s disease: a new approachMylius, Veit ; Carsten Möller, Jens ; Bohlhalter, Stephan ; Ciampi de Andrade, Daniel ; Pérez Lloret, Santiago 
diagnosis-treatment-orthostatic.pdf.jpg2013Diagnosis and treatment of orthostatic hypotension in Parkinson's diseasePérez Lloret, Santiago ; Rey, Verónica ; Pavy-Le Traon, Anne ; Rascol, Olivier 
dissociation-between-function-manipulation.pdf.jpg2022Dissociation between function and manipulation in semantic representations of motor impaired subjects : a new testGraneri, Jorge ; Dansilio, Sergio ; Martínez-Cuitiño, María Macarena ; Grasso, Lina ; Cantore, María Soledad ; Brasca, Luciana 
dual-task-readmill-training.pdf.jpg2022Dual-task treadmill training for the prevention of falls in parkinson’s disease : rationale and study designMylius, Veit ; Maes, Laura ; Negele, Katrin ; Schmid, Christine ; Sylvester, Ramona ; Brook, Caroline Sharon ; Brugger, Florian ; Pérez Lloret, Santiago ; Bansi, Jens ; Aminian, Kamiar ; Paraschiv Ionescu, Anisoara ; Gonzenbach, Roman ; Brugger, Peter 
effects-angiotensin-1-type-receptor.pdf.jpg2021Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI databaseUdovin, Lucas Daniel ; Otero Losada, Matilde ; Bordet, Sofía ; Chevalier, Guenson ; Quarracino, Cecilia ; Capani, Francisco ; Pérez Lloret, Santiago 
emerging-drugs-autonomic.pdf.jpg2013Emerging drugs for autonomic dysfunction in Parkinson's diseasePérez Lloret, Santiago ; Rey, Verónica ; Pavy-Le Traon, Anne ; Rascol, Olivier 
excessive-buccal-saliva.pdf.jpg.jpg2020Excessive buccal saliva in patients with Parkinson’s Disease of the French COPARK cohortRascol, Olivier ; Negre-Pages, Laurence ; Damier, Philippe ; Delval, Arnaud ; Derkinderen, Pascal ; Destée, Alain ; Fabbri, Margherita ; Meissner, Wassilios G. ; Rachdi, Amine ; Tison, François ; Pérez Lloret, Santiago 
fluoxetine-symptomatic-treatment-atrophy (1).pdf.jpg2021Fluoxetine for the symptomatic treatment of Multiple System Atrophy : the MSA-FLUO trialRascol, Olivier ; Cochen De Cock, Valérie ; Pavy-Le Traon, Anne ; Foubert Samier, Alexandra ; Thalamas, Claire ; Sommet, Agnès ; Rousseau, Vanessa ; Pérez Lloret, Santiago ; Fabbri, Margherita ; Azulay, Jean Philippe ; Corvol, Jean-Christophe ; Couratier, Philippe ; Damier, Philippe ; Defebvre, Luc ; Durif, Franck ; Geny, Christian ; Houeto, Jean-Luc ; Remy, Philippe ; Tranchant, Christine ; Verin, Marc ; Tison, François ; Meissner, Wassilios G. 
genetic-factors-influencing-parkinson.jpg.jpg2019Genetic factors influencing the development and treatment of cognitive impairment and psychosis in Parkinson’s diseasePérez Lloret, Santiago ; Bernath, Viviana ; Barrantes, Francisco José 
genetics-neurogenic-orthostatic.pdf.jpg2023Genetics of neurogenic orthostatic hypotension in Parkinson’s disease, results from a cross-sectional in silico studyChevalier, Guenson ; Udovin, Lucas D. ; Otero Losada, Matilde ; Bordet, Sofía ; Capani, Francisco ; Luo, Sheng ; Goetz, Christopher ; Pérez Lloret, Santiago 
heart-rate-variability-mild.pdf.jpg2020Heart rate variability and mild cognitive impairment in parkinson’s diseaseMerello, Marcelo ; Vigo, Daniel Eduardo ; Abulafia, Carolina Andrea ; Terroba-Chambi, Cinthia 
how-much-time-needed.pdf.jpg2021How much time is needed in clinical practice to reach a diagnosis of clinically established Parkinson’s disease?Rossi, Malco Damián ; Pérez Lloret, Santiago ; Merello, Marcelo 
thumb.pdf.jpg2015Management of constipation in Parkinson’s diseaseRossi, Marcelo ; Merello, Marcelo ; Pérez Lloret, Santiago 
melatonin-clinical-perspectives-neurodegeneration.pdf.jpg2019Melatonin : clinical perspectives in neurodegenerationCardinali, Daniel Pedro 
melatonin-mitochondrial-dysfunction-central-nervous.pdf.jpg2012Melatonin and mitochondrial dysfunction in the central nervous systemCardinali, Daniel Pedro ; Pagano, Eleonora S. ; Scacchi Bernasconi, Pablo A. ; Reynoso, Roxana ; Scacchi, Pablo 
melatonin-antioxidative-defense-therapeutical-implications.pdf.jpg2012Melatonin antioxidative defense : therapeutical implications for aging and neurodegenerative processesPandi Perumal, Seithikurippu R. ; BaHammam, Ahmed S. ; Spence, David Warren ; Brown, Gregory M. ; Bharti, Vijay K. ; Kaur, Charanjit ; Hardeland, Rüdiger ; Cardinali, Daniel Pedro 
melatonin-chronobiotic-cytoprotective-agent.pdf.jpg2021Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s diseasePérez Lloret, Santiago ; Cardinali, Daniel Pedro 
miedo-caidas-enfermedades.pdf.jpg2021Miedo a las caídas en las enfermedades neurodegenerativas de los ganglios basales : rol de la disfunción cognitiva, conductual y autonómica en la asociación entre la percepción de riesgo y el miedo a las caídasTerroba-Chambi, Cinthia 
neuroprotective-properties-cannabinoids.pdf.jpg2020Neuroprotective properties of cannabinoids in cellular and animal models : hypotheses and factsUdovin, Lucas Daniel ; Aguilar, Andrea ; Kobiec, Tamara ; Herrera, María Inés ; Pérez Lloret, Santiago ; Toro-Urrego, Nicolás ; Kölliker Frers, Rodolfo